DOE-SPEC-1142-2019, Beryllium Lymphocyte Proliferation Testing (BeLPT)

This specification is for beryllium lymphocyte proliferation tests (BeLPT) used for detecting whether an individual has developed a sensitization to beryllium and for clinical evaluation and diagnosis of patients for chronic beryllium disease (CBD). However, a lung biopsy is needed to fully establish the presence of CBD. This specification should be used in all contracts with laboratories for the purchase of BeLPT Services. Supersedes DOE-SPEC-1142-2001, dated 5-7-2001.

DOE-SPEC-1142-2019.pdf -- PDF Document, 382 KB
  • Hazard/Accident Analysis
ID: DOE-SPEC-1142-2019
Type: Specification
Senior Line Manager: Dressman, Kevin
Senior Line Manager Org: EH-10
OPI: EHSS - Office of Environment, Health, Safety and Security
Preparing Activity: Isaf Al-Nabulsi
Status: Current
Approved Date: Dec 16, 2019
Last Update: Dec 16, 2019
DNFSB Interest:
Invoked Standard: No
There are no Directives invoking this standard.
There are no Directives referencing this standard.